SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $623K invested in Scinai Immunotherapeutics in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

97% less capital invested

Capital invested by funds: $20.8M → $623K (-$20.2M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$154K
2
+$76K
3
+$61K
4
Morgan Stanley
Morgan Stanley
New York
+$34K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$20.7K

Top Sellers

1
-$12.6M
2
-$2.91M
3
-$701K
4
California Public Employees Retirement System
California Public Employees Retirement System
California
-$335K
5
MA
Mutual Advisors
Nebraska
-$280K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$200K
2
$171K
3
$117K
4
$76K
5
$38K
6
$7K
7
$5K
8
$4K
9
$3K
10
$1K
11
$1K
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–